Mallinckrodt

NCT00944372

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

NCT00221039

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

NCT00854750

Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis

NCT01028287

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

NCT01155141

Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH

NCT01129284

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

NCT01386554

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

NCT01455519

True Functional Restoration and Analgesia in Non-Radicular Low Back Pain

NCT01598701

Intravenous Acetaminophen in Craniotomy

NCT01544062

IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery

NCT01753401

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

NCT01838174

A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

NCT01783236

Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery

NCT01926054

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

NCT01939132

Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis

NCT02101476

An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.

NCT02391844

Open-Label Study of Oxycodone/APAP to Treat Post-Operative Pain Following Arthroscopic Knee Surgery

NCT02188017

Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

NCT02057523

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

NCT02245841

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

NCT02369211

Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV)

NCT02508935

Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

NCT02678416

Reduction in Pain Intensity Following IV or Oral Pain-relieving Products

NCT02848729

Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen

NCT02746263

Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain

NCT01891500

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

NCT02298491

CNS Sarcoidosis and Acthar Gel

NCT02446886

Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS

NCT02764697

Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

NCT02769702

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

NCT02633046

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

NCT02779153

Acthar SLE (Systemic Lupus Erythematosus)

NCT02919761

Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis

NCT02953821

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

NCT03020875

IV vs Oral Acetaminophen in Spine Fusion Perioperative Care

NCT03020966

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty

NCT03082573

Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel

NCT03126760

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

NCT02832687

Multi-dose Acetaminophen for Patients Undergoing General Anesthesia

NCT03320070

Acthar Gel in Participants With Pulmonary Sarcoidosis

NCT03198871

IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population

NCT03408405

ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

NCT03287635

Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease

NCT03419650

Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)

NCT03656692

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

NCT04080076

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

NCT02920710

ACTHAR Therapy for Central Nervous System Sarcoidosis

NCT05546047

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

NCT04169061

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

NCT02399462

Acthar for Treatment of Post-transplant FSGS

NCT02523092

Use of CXCL9 as a Biomarker of Acthar Efficacy